Nonsensitized human and mouse lymphocytes produce interferon (IFN)-a and IFN-aI/, respectively, in response to most transformed cells, as well as normal xenogeneic cells. The treatment of transformed human (WISH) and mouse (L) or normal mouse embryo (ME) cells with trypsin, pepsin, or neuraminidase resulted in a loss of the cell's ability to induce IFN-a or a/l. These findings suggested that a cell surface glycoprotein is responsible for the induction of IFN-a and al/P. The sonication of WISH, L, and ME cells released glycoproteins which retained IFNinducing activity in the soluble form. The inducing molecules from WISH, L, and ME cells had molecular weights of 130,000, 90,000, and 68,000, respectively. Further purification, plus a confirmation of the glycoprotein nature of the inducer molecule, was shown by specifically binding and eluting L cell inducer bioactivity from a concanavalin A-Sepharose affinity column.
A new class of interferon (IFN) inducers was described when Svet-Moldavsky et al. (10) demonstrated that the injection of tumor cells into nonsensitized mice resulted in IFN production. A probable in vitro correlate of this finding was the observation that nonsensitized human lymphocytes and mouse spleen cells produce IFN when cocultured with virally and spontaneously transformed syngeneic and allogeneic cells (11, 12) . In addition to transformed cells, Blalock et al. found that normal xenogeneic cells also induced IFN and that the IFN produced was of the leukocyte type (IFN-a and IFN-a/, in humans and mice, respectively) (3, 13; T. K. Hughes, E. M. Smith, and J. E. Blalock, submitted for publication). The observation that the induction of IFN required intimate contact between the inducing cells and the nonsensitized lymphocytes suggested that a foreign cell surface component was responsible for the induction (3). This report describes the partial purification and characterization of glycoproteins from the surface of normal xenogeneic and transformed allogeneic and xenogeneic cells that induce IFN production by nonsensitized lymphocytes.
MATERIALS AND METHODS
Cell cocultures and IFN induction. Transformed human amnion (WISH) and mouse L or normal primary mouse embryo (ME) cells were cultured and maintained in Eagle minimal essential medium (EMEM) supplemented with fetal bovine serum as previously described (3) . Human peripheral lymphocytes, prepared by Ficoll-Hypaque buoyant density centrifugation (4), or mouse (C57BL/6) spleen cells (8) were cocultured with WISH, L, or ME cells to induce IFN as previously described (3). Briefly, 1 x 106 inducing cells per ml were incubated with 1 x 107 lymphocytes per ml in a 100-,ul volume in wells of 96-well microtiter plates. After incubation for 18 h at 37°C in 4% C02, the culture fluids were harvested and centrifuged (1,000 x g for 5 min), and the supematant fluids were assayed for IFN.
IFN assays. The coculture samples were assayed for antiviral activity in a microplaque reduction assay with vesicular stomatitis virus as previously described (5 (14,577 U/mg; Millipore) at the indicated concentrations and lengths of time. Cells were washed three times with EMEM containing 2% fetal bovine serum before coculture to remove residual enzyme.
Solubilized inducer prepared by sonication and purificaton on a Sephacryl S-300 column (see below) was adjusted to 250 F.g of protein per ml and incubated with the enzymes as described above, plus a-mannosidase (24 U/mg; Sigma) and a-D-glucosidase (40 U/mg; Sigma).
Gel filtration column chromatography. Inducers prepared by the sonication of WISH, L, or ME cells (2 x 108) were concentrated by hydroextraction on polyethylene glycol to 1.5 ml and then chromatographed on a Sephacryl S-300 (Pharmacia, Uppsala, Sweden) column (1.5 by 60 cm) in 0.01 M PBS. The column's void volume was 28 ml, and 2-ml fractions were collected. A 0.1-ml amount of each fraction was then tested for IFN-a/,B-or IFN-a-inducing activity on 1 x 106 mouse spleen cells or human lymphocytes, respectively. to its specificity for hydrolyzing bacterial mucopolysaccharides, had no effect on the IFN-inducing ability of these cells. Similar findings were obtained with transformed mouse L cells or normal ME cells (data not shown). These data suggest that the inducing moieties on these cells are glycoproteins. Furthermore, since these enzymes act extracellularly, they support the idea that the putative glycoprotein inducer(s) is located at the cell surface. Solubilization of the IFN inducers. The homogenization and sonication of cells were both found to be effective ways to solubilize the IFN inducers in an active form. Table 2 shows a comparison of these two procedures for solubilizing the IFN inducer from ME cells. Both procedures were equally effective in terms of the amount of IFN-inducing activity found in the supernatant fluids after the procedure. Sonication had the advantage that the cells did not have to be lysed for the inducing activity to be released. Thus, the number of proteins released into the extracellular fluids was decreased, which should aid in the purification of the material. Based on these findings, 5 min of sonication was adopted as a standard procedure for the production of soluble inducer. The finding that sonication released the inducer without lysing the cells or altering their viability as determined by trypan blue dye exclusion (data not shown) is further evidence that the inducer is probably located at the cell surface.
Characterization and partial purification of the solubilized IFN inducers. The solubilized inducers from ME, WISH, and L cells were characterized by specific enzyme treatments. Table 3 shows that the inducers from these three cell types were similar in that each one's activity was destroyed by trypsin and glycosidases when assayed for IFN induction on both nonsensitized mouse spleen cells or human lymphocytes. These characteristics strongly suggest that the inducers are glycoproteins and are related to the aME, WISH, and L cell inducers were prepared and purified as described in the text. Fractions of peak inducer activity from the S-300 columns were incubated with the indicated concentrations of enzymes at pH 7 for 5 h. Treated inducer was then incubated with lymphocytes in medium containing 4% fetal bovine serum to compete for enzyme activity. After 20 h of induction, the culture supernatant fluids were assayed for IFN. MoSpl, Mouse spleen cells; HPL, human peripheral lymphocytes.
cell-associated inducers. Table 3 also shows that the soluble inducer released from normal ME cells is recognized by xenogeneic human lymphocytes but not allogeneic mouse splenocytes. These findings are consistent with the patterns observed when whole ME cells are cocultured with xenogeneic or allogeneic lymphocytes (3).
These data also indicate that sonication is not creating inducers that were not present before the solubilization procedure.
The approximate molecular weights of the IFN inducers were determined by gel filtration column chromatography (Fig. 1) . WISH, L, and ME cell inducers had molecular weights of 130,000, 90,000, and 68,000, respectively. Only one molecular weight form of each inducer was evident, and each showed very limited heterogeneity of size. Mouse and human lymphocytes recognized similar molecular weight inducers from both WISH and L cells. As expected, allogeneic mouse lymphocytes did not recognize the inducer from normal ME cells. The glycoprotein nature of the inducers, which was based on enzyme sensitivities, was confirmed by lectin affinity chromatography. Table 4 shows that the bulk of the mouse L cell inducer was retained by and eluted from a concanavalin A-Sepharose affinity column. Similar results were obtained with inducers from WISH and ME cells (data not shown). These data suggest that, at least in terms of size, there are a limited number of glycoproteins from any particular cell type which function as IFN inducers and that similar glycoproteins are recognized by nonsensitized lymphocytes from two different species.
DISCUSSION
Transformed, but not normal, allogeneic and syngeneic cells have previously been shown to induce IFN-a and IFN-a/l production by nonsensitized human and mouse lymphocytes, respectively (3, 11, 12) . These findings have suggested that within a species one manifestation of the transformed phenotype may be the ability to induce lymphocyte production of IFN. An understanding of the transformed cell substance responsible for this phenomenon could provide very important information about the initial recognition of transformed cells by the lymphoid system. This study provides the initial description of the IFN-inducing substances. Based on sensitivity to trypsin and neuraminidase, they appear to be cell surface glycoproteins. This was confirmed by showing that the inducers could be VOL. 39, 1983 on September 29, 2017 by guest http://iai.asm.org/ Downloaded from solubilized by sonication and that the solubilized material was sensitive to proteases and glycosidases. Further evidence of their glycoprotein nature was provided by the demonstration that they bind to a concanavalin A-Sepharose affinity column. The human WISH and mouse L cell inducers had molecular weights of approximately 130,000 and 90,000, respectively. Similar molecular weight fractions for each cell-type inducer were active on both nonsensitized human and mouse lymphocytes. The activity of the same or similar inducers on human and mouse lymphocytes suggests that this may be a rather common and fundamental system by which the body recognizes transformed cells.
A 68,000-molecular-weight IFN inducer from normal ME cells was demonstrable when assayed on xenogeneic nonsensitized human lymphocytes. As expected, this inducer was not recognized by nonsensitized mouse spleen cells. The demonstration of an IFN inducer from primary and secondary normal ME cells is important for at least two reasons. First, there have been reports that the mycoplasma contamination of cell lines is responsible for IFN induction by nonsensitized lymphocytes (2) . This would not be the case with primary or secondary ME cells. Also, if mycoplasma were responsible, one would not expect to remove the inducer without lysing cells or, once removed, that the various inducers would show such diversity in molecular weight. Furthermore, we have succeeded in inducing IFN-ot production in nonsensitized lymphocytes with mycoplasma-free HeLa cells (D. Dion and J. E. Blalock, manuscript in preparation). It has been shown previously that viral structure glycoproteins can induce IFN production in mouse spleen cells (6, 7) . Although we have not detected any viruses in our system, the release of C-type particles cannot be eliminated as a possible subsurface source of inducer. But C-type particles are generally poor IFN inducers (1, 9) . Because of this question, we cannot categorically state that the inducing glycoproteins are entirely surface molecules of cellular origin. However, the ability to remove the glycoprotein by mild sonication of cells strongly supports this idea.
The most important implication of this study may be the ability to use the inducer's nonsensitized lymphocyte interaction as an assay system. Differences in inducers after modification (antibody, enzymatic, chemical, etc.) or from various cell types may be quantitated based on IFN production or the lack thereof. This should allow the determination of whether the transformed cell glycoprotein inducers are modified normal cell constituents which become recognizable in a syngeneic or allogeneic system. Contrarywise, they might be shown to be new and perhaps ubiquitous transformation antigens. In either event, a number of implications for the diagnosis and therapy of tumors would be suggested.
